Add Toshiba to the list of companies developing 3-D ultrasoundtechnology. The company's Toshiba Medical Systems Europe subsidiaryin Zoetermeer, the Netherlands, has announced that it has developeda new transducer for 3-D imaging in obstetric
Add Toshiba to the list of companies developing 3-D ultrasoundtechnology. The company's Toshiba Medical Systems Europe subsidiaryin Zoetermeer, the Netherlands, has announced that it has developeda new transducer for 3-D imaging in obstetric applications.
Toshiba claims that the probe, called volume imaging transducer(VIT), is capable of real-time 3-D imaging, in which 3-D imagesare viewed during actual scanning. Most other 3-D ultrasound technologiesrequire a delay for image processing after cross-sectional slicesare acquired.
The VIT probe is a convex-array transducer that does not requireadditional devices or external computers. It can be connectedto a number of Toshiba scanners, including SSA-270A Super HG,SSH-140A Super HG, Eccocee CX, SSA-250A, and Tosbee.
In other Toshiba ultrasound news, the company's Toshiba AmericaMedical Systems subsidiary in Tustin, CA, said that it has setup a network of regional sales agents to sell its Capasee compactob/gyn scanner to private practice physicians. Toshiba believessuch a network is the most effective way to target office-basedphysicians, according to Dean Winter, director of ultrasound businessunit sales.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.